Vista Pharmaceuticals Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹16.81
- Today's High:
- ₹16.85
- Open Price:
- ₹16.81
- 52W Low:
- ₹7.28
- 52W High:
- ₹14.7
- Prev. Close:
- ₹16.52
- Volume:
- 52913
Company Statistics
- Market Cap.:
- ₹326.36 million
- Book Value:
- 9.832
- Revenue TTM:
- ₹163.22 million
- Operating Margin TTM:
- -18.77%
- Gross Profit TTM:
- ₹-4916000
- Profit Margin:
- -25.16%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Vista Pharmaceuticals Limited had its IPO on under the ticker symbol 524711.
The company operates in the Other sector and Other industry. Vista Pharmaceuticals Limited has a staff strength of 0 employees.
Stock update
Shares of Vista Pharmaceuticals Limited opened at ₹16.81 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹16.81 - ₹16.85, and closed at ₹16.85.
This is a +2% increase from the previous day's closing price.
A total volume of 52,913 shares were traded at the close of the day’s session.
In the last one week, shares of Vista Pharmaceuticals Limited have increased by +13.01%.
Vista Pharmaceuticals Limited's Key Ratios
Vista Pharmaceuticals Limited has a market cap of ₹326.36 million, indicating a price to book ratio of 0.9057 and a price to sales ratio of 0.7571.
In the last 12-months Vista Pharmaceuticals Limited’s revenue was ₹163.22 million with a gross profit of ₹-4916000 and an EBITDA of ₹0. The EBITDA ratio measures Vista Pharmaceuticals Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Vista Pharmaceuticals Limited’s operating margin was -18.77% while its return on assets stood at 0% with a return of equity of 0%.
In Q2, Vista Pharmaceuticals Limited’s quarterly earnings growth was a positive 0% while revenue growth was a negative 100%.
Vista Pharmaceuticals Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 45.8333
- PEG
Its diluted EPS in the last 12-months stands at ₹-1.371 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vista Pharmaceuticals Limited’s profitability.
Vista Pharmaceuticals Limited stock is trading at a EV to sales ratio of 1.1808 and a EV to EBITDA ratio of 12.298. Its price to sales ratio in the trailing 12-months stood at 0.7571.
Vista Pharmaceuticals Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹565.31 million
- Total Liabilities
- ₹147.55 million
- Operating Cash Flow
- ₹-12703000.00
- Capital Expenditure
- ₹12.70 million
- Dividend Payout Ratio
- 0%
Vista Pharmaceuticals Limited ended 2024 with ₹565.31 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹565.31 million while shareholder equity stood at ₹365.37 million.
Vista Pharmaceuticals Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹147.55 million in other current liabilities, 73588000.00 in common stock, ₹291.78 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹726000.00. The company’s total short-term debt was ₹46,524,000 while long-term debt stood at ₹51.79 million.
Vista Pharmaceuticals Limited’s total current assets stands at ₹209.15 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹62.72 million compared to accounts payable of ₹0 and inventory worth ₹92.77 million.
In 2024, Vista Pharmaceuticals Limited's operating cash flow was ₹-12703000.00 while its capital expenditure stood at ₹12.70 million.
Comparatively, Vista Pharmaceuticals Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹16.85
- 52-Week High
- ₹14.7
- 52-Week Low
- ₹7.28
- Analyst Target Price
- ₹
Vista Pharmaceuticals Limited stock is currently trading at ₹16.85 per share. It touched a 52-week high of ₹14.7 and a 52-week low of ₹14.7. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹11.43 and 200-day moving average was ₹10.16 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7165.5% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Vista Pharmaceuticals Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India, the United States, and internationally. It offers over the counter and prescription generic drugs consisting of tablets, capsules, and liquids covering various therapeutic categories. Vista Pharmaceuticals Limited was incorporated in 1991 and is based in Hyderabad, India.